Key cuproptosis molecular changes in cardiovascular diseases Cuproptosis is associated with major cardiac and vascular diseases, including myocardial ischemia/reperfusion injury, diabetic cardiomyopathy, sepsis-induced cardiac injury, hypertrophic cardiomyopathy, atherosclerotic cardiovascular disease, heart failure, aortic aneurysm, and hypertension
HIGH GT EXPRESSION AND INTRATUMOR DRUG ACTIVATION The high expression of GT within aggressive and drug-resistant tumors implies that GSH-conjugated prodrugs, activated at the cell surface by GT, should be particularly effective against GT-positive tumors
Occurrence, structure, biochemical properties and technological characteristics of lactoferrin
The FDA is expected to issue a decision by late 2026, which means CagriSema could potentially reach the market by late 2026 or early 2027